Helix PartnersMayo Clinic to sequence 100K participants to build genomic database for improved care and research in collaboration with HelixJanuary 9, 2020
Helix PartnersMayo Clinic to Sequence 100,000 Participants to Build Genomic Database for Improved Care and Research in Collaboration with HelixJanuary 9, 2020
Helix PartnersAre we ready to implement polygenic risk score tests in the clinic? Expanding the utility of prostate cancer polygenic risk score in multiple ethnicities and clinical best practicesOctober 17, 2019
Helix PartnersA genetic retrospective study of Maturity-Onset Diabetes of the Young (MODY) in two population health studiesOctober 16, 2019
Helix PartnersThe spectrum of mitochondrial genomic variation across 250,000 individualsOctober 16, 2019
Health SystemsFirst-line preventative genetic screening: Disease penetrance in Tier 1 inherited diseases in an all-comers population is similar to family history selected populationsOctober 16, 2019
Helix PartnersSelective constraints and pathogenicity of mitochondrial DNA variants inferred from a novel database of 196,554 unrelated individualsOctober 8, 2019
Helix PartnersPopulation Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More NevadansMay 7, 2019
Company NewsHelix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEOApril 25, 2019
Company NewsHelix Expands Focus to Population Health Solutions and Appoints Illumina Veteran Marc Stapley as CEOApril 25, 2019
Health SystemsGenetic counseling, 2030: An on‐demand service tailored to the needs of a price conscious, genetically literate, and busy worldMarch 8, 2019
Health SystemsEvaluation for Genetic Disorders in the Absence of a Clinical Indication for TestingNovember 16, 2018
